Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes

Am J Ther. 2018 Nov/Dec;25(6):e776-e779. doi: 10.1097/MJT.0000000000000784.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alanine Transaminase / blood
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Carbamates
  • Drug Therapy, Combination
  • Egypt
  • Female
  • Genotype
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / therapeutic use
  • Interferon alpha-2 / therapeutic use
  • Interferon-alpha / therapeutic use
  • Liver / pathology
  • Male
  • Middle Aged
  • Polyethylene Glycols / therapeutic use
  • Pyrrolidines
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • Sofosbuvir / therapeutic use
  • Valine / analogs & derivatives

Substances

  • Antiviral Agents
  • Carbamates
  • Imidazoles
  • Interferon alpha-2
  • Interferon-alpha
  • Pyrrolidines
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Alanine Transaminase
  • peginterferon alfa-2b
  • Valine
  • daclatasvir
  • Sofosbuvir